# FDA Inspection 1014011 - Cumberland Pharmaceuticals, Inc. - May 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/cumberland-pharmaceuticals-inc/af0d3c75-4017-4581-a15d-50533df14bc2
Source feed: FDA_Inspections

> FDA Inspection 1014011 for Cumberland Pharmaceuticals, Inc. on May 18, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014011
- Company Name: Cumberland Pharmaceuticals, Inc.
- Inspection Date: 2017-05-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 888639 - 2014-07-25](https://www.keypedia.com/records/fda_inspections/cumberland-pharmaceuticals-inc/133f0e73-4957-4fff-acc6-179d8827f2a2)
- [FDA Inspection 774914 - 2012-04-04](https://www.keypedia.com/records/fda_inspections/cumberland-pharmaceuticals-inc/3cb656f8-94bb-40e5-a199-e81a0f786c64)

Company: https://www.keypedia.com/companies/cumberland-pharmaceuticals-inc/f56adf34-cf6c-4bd2-ab50-a69b4f5e7142

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c